Fortress Biotech, Inc.'s Net Worth

$53.9 Million

Estimate Recalculated Apr 17, 2024 03:06PM EST

Who is Fortress Biotech, Inc.?

Fortress Biotech, Inc. has an estimated net worth of $53.9 Million. This is based on reported shares across multiple companies, which include Checkpoint Therapeutics, Inc., AVENUE THERAPEUTICS, INC., MUSTANG BIO, INC., NATIONAL HOLDINGS CORP, and CB Pharma Acquisition Corp..

SEC CIK

Fortress Biotech, Inc.'s CIK is 0001429260

Past Insider Trading and Trends

2023 was Fortress Biotech, Inc.'s most active year for acquiring shares with 9 total transactions. Fortress Biotech, Inc.'s most active month to acquire stocks was the month of February. 2015 was Fortress Biotech, Inc.'s most active year for disposing of shares, totalling 1 transactions. Fortress Biotech, Inc.'s most active month to dispose stocks was the month of December. 2023 saw Fortress Biotech, Inc. paying a total of $301,255.20 for 4,118,586 shares, this is the most they've acquired in one year. In 2016 Fortress Biotech, Inc. cashed out on 1,020,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NATIONAL HOLDINGS CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

CB Pharma Acquisition Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-79.38%
-1.02M
—
—
265K
May 20
Form 4
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Oct 9
Form 4
—
0
—
—
0
Mar 18
Form 4
-7.22%
-100.00K
—
—
1.28M
Jan 5
Form 3
—
0
—
—
0
No matching records found

Checkpoint Therapeutics, Inc. (CKPT) Snapshot price: $2.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.19%
193.91K
—
—
2.1M
Mar 20
Form 4
+9.07%
158.13K
—
—
1.9M
Dec 29
Form 4
+4.86%
80.91K
—
—
1.74M
Sep 25
Form 4
+5.15%
81.41K
—
—
1.66M
Jun 30
Form 4
+5.20%
78.21K
—
—
1.58M
Mar 31 - Apr 4
Form 4
+32.51%
368.91K
—
—
1.5M
Jan 5
Form 4
+36.43%
721.7K
—
—
2.7M
Mar 17
Form 3
—
0
—
—
0
No matching records found

AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $0.1223

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+13.19%
413.51K
—
—
3.55M
Apr 16
Form 4
+203.56%
2.1M
—
—
3.13M
Jan 2
Form 4
+68.15%
418.41K
$0.72
$301,255.20
1.03M
Sep 8
Form 4
+9.33%
52.42K
—
—
613.98K
Mar 31
Form 4
+134.63%
322.23K
—
—
561.56K
Dec 31 - Jan 3
Form 3
—
0
—
—
0
No matching records found

MUSTANG BIO, INC. (MBIO) Snapshot price: $1.3713

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+27.78%
419.09K
—
—
1.93M
Jan 2
Form 4
+14.16%
2.81M
—
—
22.63M
Jan 6
Form 4
+12.59%
1.13M
—
—
10.13M
Sep 30 - Mar 31
Form 3
—
0
—
—
0
No matching records found